|

Placebo oral tablet Clinical Trials

22 actively recruiting trials across 7 locations

Also known as: Control group, Matching placebo, Placebo, Placebo comparator

Pipeline

Early 1: 1Phase 2: 7Phase 3: 5Phase 4: 5Phase 1/2: 1Phase 2/3: 1

Top Sponsors

  • Yonsei University1
  • Université de Sherbrooke1
  • University of Texas at Austin1
  • University of Oxford1
  • University of Maryland, Baltimore1

Indications

  • Cancer8
  • Liver Disease4
  • Heart Disease3
  • Diabetes3
  • Breast Cancer3

Other14 trials

"The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients"
Phase 2
A Study of Cardiovascular Events iN Diabetes Plus
Phase 4
Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy
Phase 3
Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients
Phase 3
Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Phase 2/3
Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy
Phase 2
Measurement of the Hippocampal Theta Rhythm From the Outer Ear Canal
N/A
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
Phase 4
Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity
Phase 2
Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
N/A
The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients
Phase 4
The MASTER Study (MAmmary Cancer STatin ER Positive Study)
Phase 3
To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose
Phase 2
iTBS+D-Cycloserine for Youth Suicide
Phase 2

Baltimore, Maryland2 trials

Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder

Reproductive Mental Health Center

Phase 4
The Effects of Fluoxetine and/or DHEA

University of Maryland

Early 1

Mobile, Alabama1 trial

A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

Southern Cancer Center

Phase 3

La Jolla, California1 trial

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

University of California, San Diego (UCSD) - Medical Center

Phase 3

San Francisco, California1 trial

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

University of California

Phase 2

Chicago, Illinois1 trial

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 2

Austin, Texas1 trial

Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

The University of Texas at Austin

Phase 4

Lubbock, Texas1 trial

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Texas Tech University Health Sciences Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.